2-tert-Butyloxycarbonylaminomethyl-5-(4-tert-butylphenyl)-[1,3,4]oxadiazole, 95.0%, 1g

3-((2-(2-Chlorophenyl)-2-hydroxyethyl)amino)-3-methylbutanoic acid, 95.0%, 250mg

2-(DIPHENYLMETHYL)-2,6-DIAZASPIRO[3.4]OCTANE, 95.0%, 500mg

(S)-2,2'-Dimethoxy-1,1'-binaphthalene, ��97.0%, 25g

(-)-3-Dehydroshikimic acid, 98%, 500mg

4-Bromo-2-cyclopropylthiazole, 97%, 1g

3-(Hydroxymethyl)cyclobutanol, 95.0%, 250mg

Uridina, minimo 99%, per biochimica, 100 g, confezione in plastica.

1-Amino-3-(benzyloxy)cyclobutanecarboxylic acid hydrochloride, 95.0%, 1g

3-[(1S,9aR)-octahydro-2H-quinolizin-1-yl]propanoic acid - carbonic acid (1:1) hydrate, 95.0%, 250mg

(2E,4Z)-2-Cyano-5-dimethylamino-3-(4-methoxy-phenyl)-penta-2,4-dienoic acid methyl ester, 95.0%, 1g

4-(1-Imidazolyl)benzoic Acid>98.0%(GC)(T)1g

Acido dietilentriamminopentaacetico, minimo 99%, per sintesi, 100 g, confezione in plastica.